Does a heart to contralateral lung ratio of 1.1 indicate myocardial involvement in a patient with potential risk factors such as hypertension, chronic kidney disease, or a family history of amyloidosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

H/CL Ratio of 1.1 Does NOT Confirm Myocardial Involvement

A heart-to-contralateral lung (H/CL) ratio of 1.1 is below the diagnostic threshold and does not confirm ATTR cardiac amyloidosis or myocardial involvement. This ratio falls well below the required cutoffs of ≥1.5 at 1 hour or ≥1.3 at 3 hours, and critically, diagnosis cannot be made based on H/CL ratio alone without visual confirmation of diffuse myocardial uptake on SPECT imaging 1.

Critical Diagnostic Requirements

The 2021 ASNC/AHA/ASE expert consensus establishes a stepwise diagnostic algorithm that must be followed 1:

Step 1: Visual Confirmation on SPECT (Mandatory First Step)

  • SPECT imaging must first confirm diffuse myocardial radiotracer uptake before any H/CL ratio interpretation is valid 1
  • The H/CL ratio is not recommended if there is absence of myocardial uptake on SPECT 1
  • Differentiation from residual blood pool activity, focal myocardial infarction, and overlapping bone uptake is required on SPECT 1
  • If excess blood pool activity is present at 1 hour, repeat SPECT imaging at 3 hours to maximize specificity 2

Step 2: Visual Grading System (0-3 Scale)

After confirming myocardial uptake on SPECT, grade the uptake relative to ribs 1:

  • Grade 0: No myocardial uptake (normal bone uptake) - NOT consistent with ATTR-CA
  • Grade 1: Myocardial uptake less than rib uptake (equivocal, requires further evaluation)
  • Grade 2: Myocardial uptake equal to rib uptake (diagnostic for ATTR-CA if monoclonal protein excluded)
  • Grade 3: Myocardial uptake greater than rib uptake with mild/absent rib uptake (diagnostic for ATTR-CA if monoclonal protein excluded)

Step 3: H/CL Ratio (Only When Applicable)

The H/CL ratio serves a limited, adjunctive role 1:

  • H/CL ≥1.5 at 1 hour is diagnostic for ATTR-CA (when myocardial uptake confirmed on SPECT and AL amyloidosis excluded) 1
  • H/CL ≥1.3 at 3 hours is diagnostic for ATTR-CA 1
  • Your ratio of 1.1 is below both thresholds and does not meet diagnostic criteria
  • H/CL ratio is most useful when visual grade is equivocal (Grade 1 vs Grade 2) to help classify as positive or negative 1, 2
  • If visual grade is 2 or 3, diagnosis is confirmed and H/CL ratio assessment is not necessary 1

Common Pitfalls and Critical Warnings

False Positive Risk

  • Incorrect diagnosis of ATTR-CA based on planar imaging and H/CL ratio without SPECT confirmation of diffuse myocardial uptake has been observed at multiple sites 2
  • This leads to inappropriate therapy and worse patient outcomes 2
  • Excess blood pool activity on 1-hour images can be misinterpreted as positive scans 2

The Quantitative Approach Limitation

Research demonstrates that the H/CL approach results in a significantly higher proportion of equivocal studies (66% equivocal) compared to the semi-quantitative visual grading approach (8% equivocal) 3

  • The visual grading system using SPECT minimizes equivocal results and shows high concordance at both 1 and 3 hours 3
  • In cases where H/CL and visual grading were discordant, biopsy results were concordant with the SPECT visual grade, not the H/CL ratio 3

Mandatory AL Amyloidosis Exclusion

Even if imaging were positive, all patients with suspected cardiac amyloidosis must undergo screening for monoclonal plasma cell dyscrasia before confirming ATTR-CA diagnosis 1, 2:

  • Obtain serum and urine immunofixation electrophoresis
  • Obtain serum free light chain assay
  • Grade 2 or 3 uptake can be seen in >20% of patients with AL cardiac amyloidosis 1
  • Missed diagnosis of AL amyloidosis occurs when these studies are not recommended in the PYP report 2

Other Causes of Myocardial Uptake

99mTc-PYP/DPD/HMDP uptake can occur in other causes of myocardial injury 1:

  • Pericarditis
  • Myocardial infarction (regional uptake pattern)
  • Chemotherapy or drug-associated myocardial toxicity

Next Steps for This Patient

Given the H/CL ratio of 1.1 with only planar imaging provided:

  1. Review the SPECT images (if performed) to determine if there is any diffuse myocardial uptake visually 1, 2
  2. If SPECT was not performed, it must be obtained to properly interpret this study 2
  3. If SPECT shows no myocardial uptake (Grade 0), this study is negative for ATTR-CA 1
  4. If SPECT shows Grade 1 uptake, the study is equivocal and requires further evaluation to exclude AL amyloidosis 1
  5. Consider cardiac MRI if clinical suspicion remains high despite negative scintigraphy 2
  6. Consider referral to an amyloidosis expert when imaging is equivocal or discordant with clinical findings 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Equivocal Scintigraphic Findings in Suspected Cardiac Amyloidosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Tc-99m-pyrophosphate scintigraphy for the diagnosis of ATTR cardiac amyloidosis: Comparison of quantitative and semi-quantitative approaches.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.